Differences in gene copy number carried by different MHC ancestral haplotypes. Quantitation after physical separation of haplotypes by pulsed field gel electrophoresis

We have examined the hypothesis that MHC ancestral haplotypes have a specific content of genes regulating the extent of autoimmune reactions. Gene copy number was quantitated by objective densitometry after PFGE was used to separate heterozygous AHs of different lengths. Initially we analyzed examples of known gene copy number at the C4 and 21 hydroxylase loci and showed that the approach provides predictable results. We then studied heterozygotes containing one characterized and one uncharacterized AH with particular attention to the gene copy number at the C4, Cyp21, and DRB loci. Each AH studied has a characteristic gene copy number at each locus studied. The same may be true of TNF, but other possibilities must be considered. AHs are markers for extensive chromosomal segments including particular numbers of several functional genes. Since AHs mark susceptibility to autoimmune disease, differences in gene copy number may be implicated.

[1]  F. Christiansen,et al.  Some disease-associated ancestral haplotypes carry a polymorphism of TNF. , 1989, Human immunology.

[2]  S. Gitelman,et al.  Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. Santamaria,et al.  Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes. Quantitative differences at the polymorphic level. , 1989, Journal of immunology.

[4]  T. Strachan,et al.  Pulsed field gel electrophoresis identifies a high degree of variability in the number of tandem 21‐hydroxylase and complement C4 gene repeats in 21‐hydroxylase deficiency haplotypes. , 1989, The EMBO journal.

[5]  B. Uring-Lambert,et al.  Molecular basis of complete C4 deficiency. A study of three patients. , 1989, Human immunology.

[6]  E. Albert,et al.  Myasthenia Gravis: Joint Report , 1989 .

[7]  F. Christiansen,et al.  The Genomic Structure of Ancestral Haplotypes Revealed by Pulsed Field Gel Electrophoresis (PFGE) , 1989 .

[8]  F. Christiansen,et al.  Association Between Myasthenia Gravis and HLA Bw46, BfS, C4A4, C4B2, DRw9 in Chinese , 1989 .

[9]  D. Wofsy,et al.  Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. , 1989, Clinical immunology and immunopathology.

[10]  N. Morling,et al.  Association between HLA‐DR2 and Production of Tumour Necrosis Factor α and Interleukin 1 by Mononuclear Cells Activated by Lipopolysaccharide , 1988, Scandinavian journal of immunology.

[11]  F. Christiansen,et al.  Coexistence of an MHC chromosomal segment marked by HLA B17,BfS,C4A6,B1,DR7, and DQw9 in different ethnic groups. , 1988, Human immunology.

[12]  F. Christiansen,et al.  Extensive deletions and insertions in different MHC supratypes detected by pusled field gel electrophoresis , 1988, The Journal of experimental medicine.

[13]  J. Nerup,et al.  Endotoxin‐Stimulated Human Monocyte Secretion of Interleukin 1, Tumour Necrosis Factor Alpha, and Prostaglandin E2 Shows Stable Interindividual Differences , 1988, Scandinavian journal of immunology.

[14]  B. Mevåg,et al.  Restriction fragment length polymorphisms of the complement component C4 loci on chromosome 6: studies with emphasis on the determination of gene number , 1988, Annals of human genetics.

[15]  L. Flaherty.  Major histocompatibility complex polymorphism: a nonimmune theory for selection. , 1988, Human immunology.

[16]  V. Sutton,et al.  Mapping of a restriction fragment length polymorphism associated with defective DR beta 4 chain expression to the HLA-DRB1 gene. , 1988, Human immunology.

[17]  B. Beutler,et al.  The role of cachectin/TNF in endotoxic shock and cachexia. , 1988, Immunology today.

[18]  H. Mcdevitt,et al.  Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. , 1988, Nature.

[19]  P. Kay,et al.  C4 allotyping on plasma or serum: application to routine laboratories. , 1988, Human immunology.

[20]  A. Fauci,et al.  Effect of tumor necrosis factor alpha on mitogen-activated human B cells , 1987, The Journal of experimental medicine.

[21]  E. Southern,et al.  A model for the separation of large DNA molecules by crossed field gel electrophoresis. , 1987, Nucleic acids research.

[22]  D. Larhammar,et al.  Class II genes of the human major histocompatibility complex. Organization and evolutionary relationship of the DR beta genes. , 1987, The Journal of biological chemistry.

[23]  M. Carroll.  Molecular genetics of the fourth component of human complement. , 1987, Federation proceedings.

[24]  A. Wilton,et al.  HETEROGENEITY OF STEROID 21‐HYDROXYLASE GENES IN CLASSICAL CONGENITAL ADRENAL HYPERPLASIA , 1987, Journal of immunogenetics.

[25]  E. Sim,et al.  Phenotyping of human complement component C4, a class-III HLA antigen. , 1986, The Biochemical journal.

[26]  H. Colten,et al.  Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. , 1986, The Journal of clinical investigation.

[27]  P. White,et al.  Structure of human steroid 21-hydroxylase genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Bodmer,et al.  Gene clusters and the evolution of the major histocompatibility system. , 1986, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[29]  M. Tilanus,et al.  Reduced complexity of RFLP for HLA-DR typing by the use of a DR beta 3' cDNA probe. , 1986, Tissue antigens.

[30]  K. C. Reed,et al.  Rapid transfer of DNA from agarose gels to nylon membranes. , 1985, Nucleic acids research.

[31]  D. Goeddel,et al.  Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. , 1985, Nucleic acids research.

[32]  P. A. Peterson,et al.  HLA-DR beta genes vary in number between different DR specificities, whereas the number of DQ beta genes is constant. , 1985, Journal of immunology.

[33]  Bharat B. Aggarwal,et al.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.

[34]  D. Bentley,et al.  The factor B and C2 genes. , 1984, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[35]  K. Belt,et al.  The structural basis of the multiple forms of human complement component C4 , 1984, Cell.

[36]  R. Campbell,et al.  Internal homologies of the Ba fragment from human complement component Factor B, a class III MHC antigen. , 1984, The EMBO journal.

[37]  F. Christiansen,et al.  Complement allotyping in SLE: association with C4A null. , 1983, Australian and New Zealand journal of medicine.

[38]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[39]  Eric O Long,et al.  Complete sequence of an HLA‐dR beta chain deduced from a cDNA clone and identification of multiple non‐allelic DR beta chain genes. , 1983, The EMBO journal.

[40]  J. McCluskey,et al.  Disease Associations with Complotypes, Supratypes and Haplotypes , 1983, Immunological reviews.

[41]  E. Yunis,et al.  Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Dawkins.  Immunogenetics in rheumatology : musculoskeletal disease and D-penicillamine : including reports from the D-Pen-HLA 82 Workshop held in Perth, Western Australia, 14-22 April 1982 , 1982 .

[43]  B. Dupont,et al.  CLOSE GENETIC LINKAGE BETWEEN HLA AND CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) , 1977, The Lancet.